Pfizer On The Prowl For Generics

Only weeks after announcing its Wyeth acquisition, Pfizer is stepping up its profile in the generics world, looking for branded and commodity opportunities.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet